港股早評:三大指數高開逾1%,傳與蘋果合作阿里巴巴升超4%,中芯國際績後升3.2%
鮑威爾重申無需急於調整利率,隔夜美股三大指數升跌不一。昨日大幅回撤的港股三大指數高開,恒指升1.09%,國指升1.16%,恒生科技指數升1.4%。盤面上,大型科技股全線上升,傳蘋果將與阿里巴巴合作,阿里巴巴升超4%,小米升超3%有望再創新高,快手、京東升1.35%,網易、美團、騰訊均上升;半導體芯片股齊升,Q4營收增長31%,毛利率環比升至22.6%,中芯國際高開3.2%,啤酒股、豬肉概念股、蘋果概念股、香港本地銀行股紛紛上升。另一方面,光伏股、鋁業股、汽車股部分下跌,福萊特玻璃跌近2%,中國鋁業跌1.39%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.